Taiwan biological product lot release regulations
Regulations for Lot Release and Sealing of Biological Products
Current edition
Amended July 15, 2015
Current edition
Amended July 15, 2015
About this standard
Covers serums, antitoxins, vaccines, toxoids and bacterial preparations made on microbiological and immunological principles.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
No market listing is published yet.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Taiwan
- Lot release testing and sealing of vaccines and other biological productsLot release and sample testing · Sample testing
Related standards: MHRA Responsible Person (import) guidance, EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy. See all standards.